Serum Levels of Matrix Metalloproteinases 2 and 9 in Patients with Acute Myocardial Infarction Cited by

Fol. Biol. 2013, 59, 181-187

https://doi.org/10.14712/fb2013059050181

Serum Levels of Matrix Metalloproteinases 2 and 9 in Patients with Acute Myocardial Infarction

Jana Šímová^1,2, J. Škvor³, D. Slovák², I. Mazura², J. Zvárová²

¹Department of Anthropology and Human Genetics, Faculty of Science, Charles University in Prague, Czech Republic
²European Centre of Medical Informatics, Statistics and Epidemiology, Institute of Computer Science AS CR, v. v. i., and First Faculty of Medicine, Charles University in Prague, Czech Republic
³Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University in Prague, Czech Republic

Received May 2013
Accepted July 2013

Crossref Cited-by Linking

Sullivan Holly L., Gianneschi Nathan C., Christman Karen L.: Targeted nanoscale therapeutics for myocardial infarction. Biomater. Sci. 2021, 9, 1204. <https://doi.org/10.1039/D0BM01677B>
Cheng Nan, Wang Honghao, Dong Jianjian, Pan Suyue, Wang Xun, Han Yongsheng, Han Yongzhu, Yang Renmin: Elevated serum brain natriuretic peptide and matrix metalloproteinases 2 and 9 in Wilson\u2019s disease. Metab Brain Dis 2015, 30, 1087. <https://doi.org/10.1007/s11011-015-9685-x>